Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Icelandic Salmon AS (ISLAX.OL)
NOK61.00
+0.00 (+0.00%)
NO OSL Consumer Defensive Agricultural Farm Products
Address
Industriveien 51 7266
Kverva, NO
Kverva, NO
CEO
Bjorn Hembre
Website
arnarlax.is/is
IPO
2020-10-27
ISIN NO0010724701
Description
Operating as a subsidiary of SalMar ASA, Icelandic Salmon AS is primarily engaged in the aquaculture of salmon, extending its activities to the preparation, creation, and international sale of a diverse range of seafood and related products. The company, which originated in 2009, transitioned its corporate identity from Arnarlax AS to Icelandic Salmon AS in October 2020. Its main administrative office is situated in Kverva, Norway.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
NOK61.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6.0K
Beta
-0.25
Float Shares
9.84M
Free Float %
31.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -5.19% | -12.05% | +6.73% | -10.98% | -7.59% | -26.26% | -52.90% | -38.14% | -33.64% | -33.64% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
61.00
Ratings Trend (MoM)
33% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.28
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Agricultural Farm Products: +8.2%-12.3% Q4'25: +77.1% (vs Q3'24)
-
EPS growth Agricultural Farm Products: +20.0%-690.0% Q4'25: +88.1% (vs Q3'24)
-
FCF margin FCF growth · Agricultural Farm Products: +43.8%-34.0% Q4'25: -30.5% (vs Q3'24)
-
EBIT margin Agricultural Farm Products: +8.1%-24.5% Q4'25: -16.5% (vs Q3'24)
-
ROIC Agricultural Farm Products: +6.0%-8.6% Q4'25: -8.4% (vs Q3'24)
-
Share dilution Agricultural Farm Products: +0.0%+0.0% Q4'25: +6.4% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Farm Products: 0.61×-16.98× Q4'25: -21.38× (vs Q3'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
61.84M
est: 60.99M (+1.4%)
|
90.81M
est: 85.47M (+6.2%)
|
157.59M
est: 145.16M (+8.6%)
|
164.82M
est: 11.19M (+1,372.5%)
|
101.46M
est: 95.23M (+6.5%)
|
89.00M
est: 85.30M (+4.3%)
|
140.18M
140.13M – 140.23M
+64.3% YoY
|
165.78M
156.24M – 175.33M
+18.3% YoY
|
183.28M
177.55M – 189.00M
+10.6% YoY
|
| EBITDA |
7.87M
est: 9.85M (-20.1%)
|
10.48M
est: 13.80M (-24.0%)
|
41.61M
est: 23.44M (+77.5%)
|
22.85M
est: 1.32M (+1,629.9%)
|
16.46M
est: 11.24M (+46.4%)
|
-8.03M
est: 10.07M (-179.8%)
|
16.54M
16.54M – 16.55M
+64.3% YoY
|
19.56M
18.44M – 20.69M
+18.3% YoY
|
21.63M
20.95M – 22.30M
+10.6% YoY
|
| EBIT |
1.05M
est: 5.04M (-79.1%)
|
4.57M
est: 7.06M (-35.3%)
|
35.43M
est: 11.99M (+195.4%)
|
13.76M
est: 338.9K (+3,960.9%)
|
3.79M
est: 2.88M (+31.5%)
|
-21.77M
est: 2.58M (-942.8%)
|
4.24M
4.24M – 4.25M
+64.3% YoY
|
5.02M
4.73M – 5.31M
+18.3% YoY
|
5.55M
5.38M – 5.72M
+10.6% YoY
|
| Net Income |
-1.95M
est: -6.66M (+70.7%)
|
2.37M
est: 4.25M (-44.3%)
|
34.92M
est: 25.86M (+35.0%)
|
8.57M
est: -32.8K (+26,214.8%)
|
-3.09M
est: -9.91M (+68.8%)
|
-24.54M
est: -35.30M (+30.5%)
|
-1.86M
-2.59M – -1.13M
+94.7% YoY
|
17.14M
16.34M – 17.94M
+1,020.2% YoY
|
30.16M
28.93M – 31.38M
+76.0% YoY
|
| SGA |
724.0K
est: 2.36M (-69.4%)
|
603.0K
est: 3.31M (-81.8%)
|
7.16M
est: 5.62M (+27.2%)
|
10.07M
est: 883.1K (+1,040.3%)
|
6.99M
est: 7.51M (-7.0%)
|
18.91M
est: 6.73M (+181.0%)
|
11.06M
11.06M – 11.06M
+64.3% YoY
|
13.08M
12.33M – 13.83M
+18.3% YoY
|
14.46M
14.01M – 14.91M
+10.6% YoY
|
| EPS |
-0.06
est: -0.22 (+70.7%)
|
0.08
est: 0.14 (-44.3%)
|
1.13
est: 0.83 (+36.1%)
|
0.28
est: 0.00 (+27,208.1%)
|
-0.10
est: -0.32 (+68.8%)
|
-0.79
est: -1.14 (+30.7%)
|
-0.06
-0.08 – -0.04
+94.7% YoY
|
0.55
0.53 – 0.58
+1,020.2% YoY
|
0.97
0.93 – 1.01
+76.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-72.50M
OE per share TTM
-2.45
Owner's Yield
-3.21%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
76.3%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-137.8K
Shares Outstanding
30.96M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bjorn Hembre | Chief Executive Officer | — | male |
| Edvin Aspli | Chief Financial Officer | — | male |
| Johnny Indergard | Chief Operating Officer of Biology | — | — |
| Karen Osk Petursdottir | Human Resource Manager | — | — |
| Linda Bjork Gunnlaugsdottir | Chief Sales Officer | — | — |
| Rúnar Ingi Pétursson | Chief Operating Officer of Harvest Plant | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ISLAX.OL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
